Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy

Published:2013-09-24 Issue:8 Volume:109 Page:2106-2114
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Lima L,Severino P F,Silva M,Miranda A,Tavares A,Pereira S,Fernandes E,Cruz R,Amaro T,Reis C A,Dall'Olio F,Amado F,Videira P A,Santos L,Ferreira J A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2013571.pdf

Reference31 articles.

1. Ajili F, Manai M, Darouiche A, Chebil M, Boubaker S (2012) Tumor multiplicity is an independent prognostic factor of non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guerin immunotherapy. Ultrastruct Pathol 36 (5): 320–324.

2. Alexandroff AB, Nicholson S, Patel PM, Jackson AM (2010) Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer. Immunotherapy 2 (4): 551–560.

3. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Bohle A, Palou-Redorta J, Roupret M (2011) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 59 (6): 997–1008.

4. Becich MJ, Carroll S, Ratliff TL (1991) Internalization of bacille Calmette-Guerin by bladder tumor cells. J Urol 145 (6): 1316–1324.

5. Bohle A, Bock PR (2004) Intravesical bacille Calmette-Guerin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. Urology 63 (4): 682–686.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered Glycosylation in Progression and Management of Bladder Cancer;Molecules;2023-04-13

2. Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape;Société Internationale d’Urologie Journal;2022-07-15

3. Role of Biomarkers in Personalized Medicine;Cancer Biomarkers in Diagnosis and Therapeutics;2022

4. Blood-based protein biomarkers in bladder urothelial tumors;Journal of Proteomics;2021-09

5. Mucins as anti-cancer targets: perspectives of the glycobiologist;Glycoconjugate Journal;2021-03-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3